Management of bone health in postmenopausal women

被引:7
|
作者
Eastell, R [1 ]
机构
[1] Univ Sheffield, Div Clin Sci N, Sect Human Metab, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
关键词
osteoporosis; treatment; alendronate; risedronate; calcitonin; raloxifene; teriparatide;
D O I
10.1159/000087761
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a major public health problem. We now have an approach to case finding that involves the measurement of bone mineral density in people at high risk of fractures. The management of the individual includes the identification of risk factors, the choice of optimal therapy and the encouragement of long-term adherence with the planned treatment. The drugs that are available for the prevention of fractures are classed as anticatabolic or anabolic. The efficacy of these agents can be evaluated in the individual by monitoring changes in bone mineral density or bone turnover markers. Copyright (c) 2005 S. Karger AG, Basel.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [1] Hormones and bone health in postmenopausal women
    Robert Lindsay
    [J]. Endocrine, 2004, 24 : 223 - 230
  • [2] Hormones and bone health in postmenopausal women
    Lindsay, R
    [J]. ENDOCRINE, 2004, 24 (03) : 223 - 230
  • [3] Bone health and osteoporosis in postmenopausal women
    de Villiers, Tobias Johannes
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2009, 23 (01) : 73 - 85
  • [5] Isoflavones and bone health in perimenopausal and postmenopausal women
    Lambert, Max Norman Tandrup
    Jeppesen, Per Bendix
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2018, 21 (06): : 475 - 480
  • [6] Bone health status of postmenopausal Chinese women
    Lo, Sue S. T.
    [J]. HONG KONG MEDICAL JOURNAL, 2015, 21 (06) : 536 - 541
  • [7] Vitamin D and bone health in postmenopausal women
    Malabanan, AO
    Holick, MF
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2003, 12 (02): : 151 - 156
  • [8] Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience
    Douglas Tremblay
    Vaibhav Patel
    Kenneth M. Fifer
    Jessica Caro
    Olivia Kolodka
    John Mandelli
    Charles L. Shapiro
    [J]. Supportive Care in Cancer, 2018, 26 : 197 - 202
  • [9] Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience
    Tremblay, Douglas
    Patel, Vaibhav
    Fifer, Kenneth M.
    Caro, Jessica
    Kolodka, Olivia
    Mandelli, John
    Shapiro, Charles L.
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (01) : 197 - 202
  • [10] Quantitative ultrasound (QUS) of bone in the management of postmenopausal women
    Gambacciani, M
    de Aloysio, D
    Elia, D
    van der Mooren, MJ
    Hadji, P
    Wüster, C
    [J]. MATURITAS, 2004, 47 (02) : 139 - 149